Related Experiment Videos
Microfluidic liquid chromatography system for proteomic applications and biomarker screening
Iulia M Lazar1, Phichet Trisiripisal, Hetal A Sarvaiya
1Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Polytechnic Institute and State University, Washington St. Bio II/283, Blacksburg, Virginia 24061, USA.
Analytical Chemistry
|August 2, 2006
Summary
This study introduces a compact microfluidic liquid chromatography (LC) system for proteomics. The device, integrated onto a small chip, shows comparable performance to traditional systems for identifying cancer biomarkers.
Area of Science:
- Proteomics
- Analytical Chemistry
- Biotechnology
Background:
- Proteomic investigations require efficient separation techniques.
- Conventional liquid chromatography (LC) systems can be bulky and complex.
- Miniaturization offers potential for enhanced throughput and reduced sample consumption.
Purpose of the Study:
- To describe a novel microfluidic liquid chromatography (LC) system for stand-alone proteomic analysis.
- To evaluate the performance of the microfluidic LC system against conventional benchtop instrumentation.
- To demonstrate the potential of the microfluidic device for biomarker screening.
Main Methods:
- Development of a microfluidic LC system integrating pump, valve, separation column, and electrospray interface on a glass microchip.
- Utilizing electroosmotic pumping for eluent propulsion and sample valving.
- Analysis of tryptic digests from MCF7 breast cancer cell line protein extracts using both microfluidic and conventional LC platforms.
Main Results:
- The microfluidic LC system demonstrated flow rates compatible with nano-LC platforms.
- Performance was comparable to benchtop instrumentation, with a 75% overlap in identified proteins.
- Identified 77 proteins, 39 with p < 0.001, and 5 known cancer-specific biomarkers from a protein-rich fraction.
Conclusions:
- The integrated microfluidic LC system is a viable alternative to conventional systems for proteomic analysis.
- The device shows promise for high-throughput screening of cancer biomarkers.
- Miniaturized LC platforms can achieve high performance in complex biological sample analysis.